Literature DB >> 9443983

Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction.

M L Falchetti1, A Levi, P Molinari, R Verna, E D'Ambrosio.   

Abstract

Telomeric Repeat Amplification Protocol (TRAP) is a sensitive procedure to measure telomerase activity in small samples of cell or tissue extracts. Due to the strict correlation between high levels of telomerase activity and neoplastic transformation, TRAP assay could provide an important diagnostic marker of malignancy. Although the original TRAP assay is very sensitive and some improvements have been described, occasional artifacts still persist in the modified procedures. Here we describe how changes in the sequence of the primer used for the amplification step enhance the reproducibility and sensitivity in the TRAP assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443983      PMCID: PMC147323          DOI: 10.1093/nar/26.3.862

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  6 in total

1.  Telomeres and telomerase: a simple picture becomes complex.

Authors:  V Lundblad; W E Wright
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

2.  Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay.

Authors:  G Krupp; K Kühne; S Tamm; W Klapper; K Heidorn; A Rott; R Parwaresch
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.

Authors:  W E Wright; J W Shay; M A Piatyszek
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

5.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

6.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

  6 in total
  5 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.

Authors:  M L Falchetti; R Pallini; L M Larocca; R Verna; E D'Ambrosio
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

3.  Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.

Authors:  Carlo Vicentini; Giovanni Luca Gravina; Adriano Angelucci; Esterina Pascale; Ettore D'Ambrosio; Paola Muzi; Gabriella Di Leonardo; Antonio Fileni; Andrea Tubaro; Claudio Festuccia; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-29       Impact factor: 4.553

4.  SirT1--a sensor for monitoring self-renewal and aging process in retinal stem cells.

Authors:  Chi-Hsien Peng; Yuh-Lih Chang; Chung-Lan Kao; Ling-Ming Tseng; Chih-Chia Wu; Yu-Chih Chen; Ching-Yao Tsai; Lin-Chung Woung; Jorn-Hon Liu; Shih-Hwa Chiou; Shih-Jen Chen
Journal:  Sensors (Basel)       Date:  2010-06-21       Impact factor: 3.576

5.  Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function.

Authors:  Dennis A Simpson; Elizabeth Livanos; Timothy P Heffernan; William K Kaufmann
Journal:  J Carcinog       Date:  2005-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.